Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Lifestyle Changes for the Treatment of Nonalcoholic Fatty Liver Disease - A 2015-19 Update

Author(s): Maria L. Petroni, Lucia Brodosi, Francesca A. Barbanti, Silvia di Domizio, Salvo Petta and Giulio Marchesini*

Volume 26, Issue 10, 2020

Page: [1110 - 1118] Pages: 9

DOI: 10.2174/1381612826666200204095401

Price: $65

conference banner
Abstract

Background: Lifestyle interventions aimed at weight loss have been associated with improved liver enzymes, reduced intrahepatic triglyceride content, and improved histology (including reduced fibrosis stage).

Objective: To revise the evidence on the beneficial effects of lifestyle changes accumulated since 2015, following the publication of the pivotal Cuban experience with histologic outcome.

Methods: A PubMed search covering the period 2015 to July 2019 was carried out. All retrieved references were analyzed and double-checked by authors.

Results: 20 new studies were identified; in addition, two relevant studies provided new evidence. Thirteen studies were classified as randomized, controlled studies, three as proof-of-concept/pilot studies, four as cohort observational studies. In an attempt to maintain a closer contact between participants and the treatment center, a study implemented regular phone calls, another an e-mail service, a third was based on text messages, and finally, a study was totally web-based. Notably, the web-based treatment, accessed following intense motivational interviewing, was not less effective than a standard group-based behavior program.

Conclusion: Lifestyle changes should form the basis of any NAFLD intervention. Information technology provides the opportunity to expand treatment, bypassing job and time constraints in younger patients, and to maintain long-term contact between patients and therapists in the NAFLD population.

Keywords: Behavior therapy, cirrhosis, fibrosis, food intake, information technology, physical activity steatosis.

« Previous Next »
[1]
LaBrecque DR, Abbas Z, Anania F, et al. Review Team. World Gastroenterology Organisation.World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014; 48(6): 467-73.
[http://dx.doi.org/10.1097/MCG.0000000000000116] [PMID: 24921212]
[2]
Fan JG, Jia JD, Li YM, et al. Chinese Association for the Study of Liver Disease. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010. Chinese J Hepatology 2010; 18:163-166). J Dig Dis 2011; 12(1): 38-44.
[http://dx.doi.org/10.1111/j.1751-2980.2010.00476.x] [PMID: 21276207]
[3]
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016; 64(6): 1388-402.
[http://dx.doi.org/10.1016/j.jhep.2015.11.004] [PMID: 27062661]
[4]
Italian Association for the Study of the Liver (AISF). AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Dig Liver Dis 2017; 49(5): 471-83.
[http://dx.doi.org/10.1016/j.dld.2017.01.147] [PMID: 28215516]
[5]
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67(1): 328-57.
[http://dx.doi.org/10.1002/hep.29367] [PMID: 28714183]
[6]
Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010; 51(1): 121-9.
[http://dx.doi.org/10.1002/hep.23276] [PMID: 19827166]
[7]
Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002; 25(12): 2165-71.
[http://dx.doi.org/10.2337/diacare.25.12.2165] [PMID: 12453955]
[8]
Wong VW, Wong GL, Chan RS, et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol 2018; 69(6): 1349-56.
[http://dx.doi.org/10.1016/j.jhep.2018.08.011] [PMID: 30142427]
[9]
Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology 2015; 149(2): 379-88.
[http://dx.doi.org/10.1053/j.gastro.2015.04.014] [PMID: 25917783]
[10]
Bellentani S, Dalle Grave R, Suppini A, Marchesini G. Fatty Liver Italian N. Fatty Liver Italian Network.. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology 2008; 47(2): 746-54.
[http://dx.doi.org/10.1002/hep.22009] [PMID: 18098321]
[11]
Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C. Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol 2016; 14(10): 1398-411.
[http://dx.doi.org/10.1016/j.cgh.2016.04.036] [PMID: 27155553]
[12]
Zelber-Sagi S, Salomone F, Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int 2017; 37(7): 936-49.
[http://dx.doi.org/10.1111/liv.13435] [PMID: 28371239]
[13]
Petta S, Marchesini G, Caracausi L, et al. Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Hepatol 2013; 59(6): 1169-76.
[http://dx.doi.org/10.1016/j.jhep.2013.07.037] [PMID: 23933265]
[14]
Valenzuela R, Videla LA. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct 2011; 2(11): 644-8.
[http://dx.doi.org/10.1039/c1fo10133a] [PMID: 22008843]
[15]
Marchesini G, Petta S, Dalle Grave R. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice. Hepatology 2016; 63(6): 2032-43.
[http://dx.doi.org/10.1002/hep.28392] [PMID: 26663351]
[16]
Zelber-Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011; 17(29): 3377-89.
[http://dx.doi.org/10.3748/wjg.v17.i29.3377] [PMID: 21876630]
[17]
Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 2017; 67(4): 829-46.
[http://dx.doi.org/10.1016/j.jhep.2017.05.016] [PMID: 28545937]
[18]
Hernandez-Rodas MC, Valenzuela R, Videla LA. Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease. Int J Mol Sci 2015; 16(10): 25168-98.
[http://dx.doi.org/10.3390/ijms161025168] [PMID: 26512643]
[19]
Wong VW, Chan RS, Wong GL, et al. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 2013; 59(3): 536-42.
[http://dx.doi.org/10.1016/j.jhep.2013.04.013] [PMID: 23623998]
[20]
Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 2015; 149: 367-78.e5. quiz e14-5.
[http://dx.doi.org/10.1053/j.gastro.2015.04.005]
[21]
Agebratt C, Ström E, Romu T, et al. A randomized study of the efects of additional fruit and nuts consumption on hepatic fat content, cardiovascular risk factors and basal metabolic rate. PLoS One 2016; 11(1)e0147149
[http://dx.doi.org/10.1371/journal.pone.0147149] [PMID: 26788923]
[22]
Razavi Zade M, Telkabadi MH, Bahmani F, Salehi B, Farshbaf S, Asemi Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. Liver Int 2016; 36(4): 563-71.
[http://dx.doi.org/10.1111/liv.12990] [PMID: 26503843]
[23]
Dong F, Zhang Y, Huang Y, et al. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep 2016; 6: 36783.
[http://dx.doi.org/10.1038/srep36783] [PMID: 27830836]
[24]
Pugh CJ, Sprung VS, Jones H, et al. Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease. Int J Obes 2016; 40(12): 1927-30.
[http://dx.doi.org/10.1038/ijo.2016.123] [PMID: 27439593]
[25]
Shojaee-Moradie F, Cuthbertson DJ, Barrett M, et al. Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD. J Clin Endocrinol Metab 2016; 101(11): 4219-28.
[http://dx.doi.org/10.1210/jc.2016-2353] [PMID: 27583475]
[26]
Aoyama T, Takada H, Uchiyama A, et al. A customized online nutrition guidance system is effective for teating patients with nonalcoholic fatty liver disease by supporting continuity of diet therapy at home: a pilot study. Intern Med 2017; 56(13): 1651-6.
[http://dx.doi.org/10.2169/internalmedicine.56.8187] [PMID: 28674352]
[27]
Berzigotti A, Albillos A, Villanueva C, et al. Ciberehd SportDiet Collaborative Group. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study. Hepatology 2017; 65(4): 1293-305.
[http://dx.doi.org/10.1002/hep.28992] [PMID: 27997989]
[28]
Gelli C, Tarocchi M, Abenavoli L, Di Renzo L, Galli A, De Lorenzo A. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(17): 3150-62.
[http://dx.doi.org/10.3748/wjg.v23.i17.3150] [PMID: 28533672]
[29]
Houghton D, Thoma C, Hallsworth K, et al. Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial. Clin Gastroenterol Hepatol 2017; 15: 96-102 e3.
[http://dx.doi.org/10.1016/j.cgh.2016.07.031]
[30]
Khoo J, Hsiang J, Taneja R, Law NM, Ang TL. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial. Diabetes Obes Metab 2017; 19(12): 1814-7.
[http://dx.doi.org/10.1111/dom.13007] [PMID: 28503750]
[31]
Chan DFY, So HK, Hui SCN, et al. Dietitian-led lifestyle modification programme for obese Chinese adolescents with non-alcoholic fatty liver disease: a randomized controlled study. Int J Obes 2018; 42(9): 1680-90.
[http://dx.doi.org/10.1038/s41366-018-0010-8] [PMID: 29453464]
[32]
Mazzotti A, Caletti MT, Brodosi L, et al. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers. J Hepatol 2018; 69(5): 1155-63.
[http://dx.doi.org/10.1016/j.jhep.2018.07.013] [PMID: 30290973]
[33]
Properzi C, O’Sullivan TA, Sherriff JL, et al. Ad libitum Mediterranean and low-fat diets both sgnificantly reduce hepatic steatosis: a randomized controlled trial. Hepatology 2018; 68(5): 1741-54.
[http://dx.doi.org/10.1002/hep.30076] [PMID: 29729189]
[34]
Tutino V, De Nunzio V, Caruso MG, et al. Aerobic physical activity and a low glycemic diet reduce the AA/EPA ratio in red blood cell membranes of patients with NAFLD. Nutrients 2018; 10(9): 10.
[http://dx.doi.org/10.3390/nu10091299] [PMID: 30217048]
[35]
Axley P, Kodali S, Kuo YF, et al. Text messaging approach improves weight loss in patients with nonalcoholic fatty liver disease: A randomized study. Liver Int 2018; 38(5): 924-31.
[http://dx.doi.org/10.1111/liv.13622] [PMID: 29117472]
[36]
Abdelbasset WK, Tantawy SA, Kamel DM, Alqahtani BA, Soliman GS. A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. Medicine (Baltimore) 2019; 98(12): e14918
[http://dx.doi.org/10.1097/MD.0000000000014918] [PMID: 30896648]
[37]
Deibert P, Lazaro A, Schaffner D, et al. Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. World J Gastroenterol 2019; 25(9): 1116-31.
[http://dx.doi.org/10.3748/wjg.v25.i9.1116] [PMID: 30862999]
[38]
Reginato E, Pippi R, Aiello C, et al. Effect of short term intensive lifestyle intervention on hepatic steatosis indexes in adults with obesity and/or type 2 diabetes. J Clin Med 2019; 8(6): 8.
[http://dx.doi.org/10.3390/jcm8060851] [PMID: 31207986]
[39]
Shen J, Wong GL, Chan HL, et al. PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2015; 30(1): 139-46.
[http://dx.doi.org/10.1111/jgh.12656] [PMID: 25040896]
[40]
Vilar-Gomez E, Yasells-Garcia A, Martinez-Perez Y, et al. Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention. Hepatology 2016; 63(6): 1875-87.
[http://dx.doi.org/10.1002/hep.28484] [PMID: 26849287]
[41]
Vilar-Gomez E, Calzadilla-Bertot L, Friedman SL, et al. Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2017; 45(2): 332-44.
[http://dx.doi.org/10.1111/apt.13860] [PMID: 27862096]
[42]
Lien LF, Brown AJ, Ard JD, et al. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension 2007; 50(4): 609-16.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.089458] [PMID: 17698724]
[43]
Di Loreto C, Fanelli C, Lucidi P, et al. Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects. Diabetes Care 2003; 26(2): 404-8.
[http://dx.doi.org/10.2337/diacare.26.2.404] [PMID: 12547870]
[44]
Moscatiello S, Di Luzio R, Bugianesi E, et al. Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study. Obesity (Silver Spring) 2011; 19(4): 763-70.
[http://dx.doi.org/10.1038/oby.2010.254] [PMID: 20966900]
[45]
Khoo J, Hsiang JC, Taneja R, et al. Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease. Liver Int 2019; 39(5): 941-9.
[http://dx.doi.org/10.1111/liv.14065] [PMID: 30721572]
[46]
Petroni ML, Montesi L, Colosimo S, Caletti MT, Mazzotti A, Marchesini G. Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study. Endocrinol Diabetes Metab 2019; 2(4): e00082
[http://dx.doi.org/10.1002/edm2.82] [PMID: 31592154]
[47]
Berzigotti A, Garcia-Tsao G, Bosch J, et al. Portal Hypertension Collaborative Group. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology 2011; 54(2): 555-61.
[http://dx.doi.org/10.1002/hep.24418] [PMID: 21567436]
[48]
Assy N, Nassar F, Nasser G, Grosovski M. Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterol 2009; 15(15): 1809-15.
[http://dx.doi.org/10.3748/wjg.15.1809] [PMID: 19370776]
[49]
Soto-Alarcon SA, Valenzuela R, Valenzuela A, Videla LA. Liver protective effects of extra virgin olive oil: interaction between its chemical composition and the cell-signaling pathways involved in protection. Endocr Metab Immune Disord Drug Targets 2018; 18(1): 75-84.
[PMID: 29141573]
[50]
Gepner Y, Shelef I, Komy O, et al. The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. J Hepatol 2019; 71(2): 379-88.
[http://dx.doi.org/10.1016/j.jhep.2019.04.013] [PMID: 31075323]
[51]
Ma J, Hennein R, Liu C, et al. Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease. Gastroenterology 2018; 155(1): 107-17.
[http://dx.doi.org/10.1053/j.gastro.2018.03.038] [PMID: 29604292]
[52]
Baratta F, Pastori D, Polimeni L, et al. Adherence to Mediterranean diet and non-alcoholic fatty liver disease: Effect on insulin resistance. Am J Gastroenterol 2017; 112(12): 1832-9.
[http://dx.doi.org/10.1038/ajg.2017.371] [PMID: 29063908]
[53]
Estruch R, Ros E, Salas-Salvadó J, et al. PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368(14): 1279-90.
[http://dx.doi.org/10.1056/NEJMoa1200303] [PMID: 23432189]
[54]
Centis E, Moscatiello S, Bugianesi E, et al. Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease. J Hepatol 2013; 58(4): 771-7.
[http://dx.doi.org/10.1016/j.jhep.2012.11.031] [PMID: 23201248]
[55]
Prochaska JO, Redding CA, Evers KE. The transtheoretical model and stages of change Health behavior and health education: theory, research, and practice. San Francisco, CA: Jossey-Bass 2002.
[56]
Stewart KE, Haller DL, Sargeant C, Levenson JL, Puri P, Sanyal AJ. Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models. Liver Int 2015; 35(3): 936-43.
[http://dx.doi.org/10.1111/liv.12483] [PMID: 24521540]
[57]
Miller WR, Rollnick S. Motivational Interviewing. 2nd ed. New York: The Guilford Press 2002.
[58]
Hall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health 2015; 36: 393-415.
[http://dx.doi.org/10.1146/annurev-publhealth-031914-122855] [PMID: 25785892]
[59]
Siopis G, Chey T, Allman-Farinelli M. A systematic review and meta-analysis of interventions for weight management using text messaging. J Hum Nutr Diet 2015; 28(Suppl. 2): 1-15.
[http://dx.doi.org/10.1111/jhn.12207] [PMID: 24480032]
[60]
Teeriniemi AM, Salonurmi T, Jokelainen T, et al. A randomized clinical trial of the effectiveness of a Web-based health behaviour change support system and group lifestyle counselling on body weight loss in overweight and obese subjects: 2-year outcomes. J Intern Med 2018; 284(5): 534-45.
[http://dx.doi.org/10.1111/joim.12802] [PMID: 29974563]
[61]
Patel YA, Imperial JC, Muir AJ, et al. Baseline parameters in clinical trials for nonalcoholic steatohepatitis: Recommendations from the Liver Forum. Gastroenterology 2017; 153: 621-5 e7.

Rights & Permissions Print Cite
Article Metrics
51
3
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy